Solesence, Inc. (SLSN) Key Metrics
SLSN valuation today
Trailing 12 months · as of October 18, 2026- Market cap
- $63.6M
- Enterprise value
- $79.6M
- P/E (TTM)
- —
- Forward P/E
- 11.4
- PEG ratio
- —
- Price / sales
- 1.1
- Price / book
- 4.4
- EV / EBITDA
- 27.7
- Dividend yield
- —
- Beta
- 1.38
SLSN key metrics, 2021–2025
Fiscal year ended December 31, 2025 · U.S. dollarsSLSN returns How much profit the business earns on the capital it uses.
SLSN per-share figures Results divided by the shares outstanding at year-end.
SLSN financial health Debt, liquidity and how easily interest is covered.
SLSN efficiency & capital use Working capital cycle and where the cash goes.
SLSN valuation history
SLSN returns on capital
Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.
SLSN debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease liabilities.
SLSN price vs earnings per share
SLSN key metrics
2021–2025| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Valuation | |||||
| Market capitalization | $116.1M | — | — | — | — |
| Enterprise value | $139.2M | — | — | — | — |
| P/E ratio | 64.9 | — | — | — | — |
| Price / sales | 1.9 | — | — | — | — |
| Price / book | 6.6 | — | — | — | — |
| EV / sales | 2.2 | — | — | — | — |
| EV / EBITDA | 37.7 | — | — | — | — |
| Earnings yield | 1.5% | — | — | — | — |
| Free cash flow yield | −9.2% | — | — | — | — |
| Share price at fiscal year-end | $1.60 | — | — | — | — |
| Per share | |||||
| Revenue per share | $0.86 | $0.80 | $0.75 | $0.76 | $0.63 |
| Earnings per share | $0.02 | $0.07 | −$0.09 | −$0.05 | $0.05 |
| Operating cash flow per share | −$0.12 | $0.03 | −$0.04 | −$0.03 | $0.05 |
| Free cash flow per share | −$0.15 | −$0.04 | −$0.06 | −$0.09 | $0.01 |
| Cash per share | $0.02 | $0.02 | $0.03 | $0.04 | $0.01 |
| Book value per share | $0.24 | $0.23 | $0.04 | $0.12 | $0.16 |
| Tangible book value per share | $0.24 | $0.23 | $0.04 | $0.12 | $0.16 |
| Capex per share | $0.03 | $0.07 | $0.02 | $0.06 | $0.04 |
| Debt per share | $0.34 | $0.24 | $0.43 | $0.37 | $0.31 |
| Shares outstanding | 72.6M | 65.0M | 49.6M | 49.1M | 47.0M |
| Change in shares outstanding | +11.6% | +31.2% | +0.9% | +4.4% | — |
| Returns & profitability | |||||
| Return on equity (ROE) | 11.0% | 50.3% | −116.3% | −40.0% | 31.1% |
| Return on invested capital (ROIC) | 4.3% | 19.4% | −13.0% | −8.3% | 11.7% |
| Return on assets (ROA) | 3.6% | 10.2% | −13.2% | −8.5% | 8.2% |
| Return on tangible assets | 3.6% | 8.5% | −13.4% | −7.8% | 8.2% |
| Free cash flow margin | −17.3% | −4.9% | −8.2% | −12.0% | 1.5% |
| Income quality (OCF / net income) | −4.79 | 0.47 | — | — | 1.00 |
| Financial health | |||||
| Total debt | $24.3M | $15.3M | $21.3M | $18.1M | $14.8M |
| Cash & short-term investments | $1.3M | $1.4M | $1.7M | $2.2M | $657,000 |
| Net debt | $23.0M | $13.9M | $19.5M | $15.9M | $14.1M |
| Debt / equity | 1.38 | 1.02 | 11.18 | 3.20 | 1.98 |
| Debt / assets | 0.49 | 0.31 | 0.65 | 0.54 | 0.52 |
| Net debt / EBITDA | 6.24 | 2.29 | — | — | 3.55 |
| Current ratio | 2.07 | 1.14 | 1.05 | 1.20 | 1.58 |
| Quick ratio | 0.74 | 0.35 | 0.40 | 0.56 | 0.75 |
| Interest coverage | 1.7 | 7.7 | -4.2 | -5.9 | 2.2 |
| Working capital | $14.8M | $3.6M | $713,000 | $2.8M | $4.3M |
| Invested capital | $40.7M | $28.8M | $21.4M | $21.6M | $21.6M |
| Tangible asset value | $17.6M | $14.9M | $1.9M | $5.6M | $7.5M |
| Net current asset value | −$3.6M | −$5.7M | −$14.7M | −$11.3M | −$9.3M |
| Graham number | $0.37 | $0.58 | — | — | $0.42 |
| Graham net-net per share | −$0.23 | −$0.31 | −$0.44 | −$0.36 | −$0.30 |
| Capital allocation | |||||
| Capex / revenue | 3.5% | 8.7% | 2.8% | 7.6% | 6.4% |
| Capex / operating cash flow | — | 231.3% | — | — | 80.7% |
| Capex / depreciation | 2.39 | 4.91 | 1.42 | 4.98 | 4.13 |
| Stock-based compensation / revenue | 0.9% | 1.4% | 2.1% | 1.7% | 0.5% |
| R&D / revenue | 6.6% | 7.3% | 10.3% | 8.1% | 7.6% |
| SG&A / revenue | 16.8% | 13.8% | 20.2% | 20.3% | 13.2% |
| Efficiency | |||||
| Days sales outstanding | 34.4 | 29.1 | 40.1 | 42.4 | 48.8 |
| Days of inventory on hand | 153.7 | 152.9 | 116.8 | 94.1 | 107.0 |
| Days payables outstanding | 59.8 | 86.2 | 81.5 | 67.1 | 68.2 |
| Cash conversion cycle (days) | 128.4 | 95.8 | 75.5 | 69.4 | 87.5 |
| Receivables turnover | 10.60 | 12.56 | 9.10 | 8.61 | 7.49 |
| Payables turnover | 6.11 | 4.23 | 4.48 | 5.44 | 5.35 |
| Inventory turnover | 2.37 | 2.39 | 3.12 | 3.88 | 3.41 |
| Asset turnover | 1.24 | 1.26 | 1.12 | 1.20 | 1.04 |
| Average receivables | $5.9M | $4.2M | $4.1M | $4.3M | $3.9M |
| Average payables | $7.5M | $8.5M | $6.6M | $5.3M | $3.9M |
| Average inventory | $19.4M | $15.1M | $9.4M | $7.5M | $6.1M |
| Intangibles / total assets | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Computed from SLSN's annual financial statements (latest annual report filed March 31, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.
SLSN valuation and financial ratios
At the end of fiscal 2025 (December 31, 2025), Solesence traded at 64.9 times earnings. Solesence earned a return on equity of 11.0% and a return on invested capital of 4.3% in fiscal 2025. It ended the year with $24.3 million of debt and $1.3 million in cash and short-term investments, net debt of $23.0 million. The share count rose 54.3% from 47.0M to 72.6M over 4 years.
See the SLSN income statement, the SLSN chart for price history, or the SLSN stock overview for the latest quote and news.
SLSN key metrics FAQ
What is Solesence's P/E ratio?
Solesence traded at 64.9 times earnings at the end of fiscal 2025.
What is Solesence's EV/EBITDA?
Solesence's enterprise value was 37.7 times EBITDA at the end of fiscal 2025 (enterprise value $139.2 million, EBITDA $3.7 million); the current EV/EBITDA is 27.7.
What is Solesence's return on equity?
Solesence's return on equity (ROE) was 11.0% in fiscal 2025: net income of $1.8 million on average shareholders' equity of $16.3 million.
What is Solesence's ROIC?
Solesence's return on invested capital was 4.3% in fiscal 2025, using after-tax operating income divided by average debt plus equity minus cash.
How much debt does Solesence have?
Solesence had total debt of $24.3 million at the end of fiscal 2025, a debt-to-equity ratio of 1.38 and $23.0 million of net debt (6.24 times EBITDA).
What is Solesence's free cash flow yield?
Solesence generated -$10.7 million of free cash flow in fiscal 2025, a free cash flow yield of −9.2% on its market value at year-end ($116.1 million).
What is Solesence's current ratio?
Solesence's current ratio was 2.07 at the end of fiscal 2025: current assets were 2.07 times current liabilities.